-
Zydus Cadila’s Covid vaccine to be launched in October: Report
This will be the first vaccine to be administered to the age group of 12 to 18 years in India.
-
Zydus Cadila’s Virafin gets emergency authorisation for COVID-19 treatment
A single-dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients, Zydus Cadila said
-
COVID-19: Antibodies may last from days to years, depending on severity, says study
Recovered patients with low levels of neutralising antibodies may still be protected from reinfection if they have robust immunity in the form of the
